Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Utility of Diagnostic Mammography as the Primary Imaging Modality for Palpable Lumps in Women With Almost Entirely Fatty Breasts.

Linden OE, Hayward JH, Price ER, Kelil T, Joe BN, Lee AY.

AJR Am J Roentgenol. 2020 Apr;214(4):938-944. doi: 10.2214/AJR.19.21760. Epub 2020 Feb 5.

PMID:
32023120
2.

Role of Breast MRI in the Evaluation and Detection of DCIS: Opportunities and Challenges.

Greenwood HI, Wilmes LJ, Kelil T, Joe BN.

J Magn Reson Imaging. 2019 Nov 20. doi: 10.1002/jmri.26985. [Epub ahead of print] Review.

PMID:
31746088
3.

More Lives Risked with Risk-based versus Age-based Breast Cancer Screening.

Joe BN, Hayward JH.

Radiology. 2019 Aug;292(2):329-330. doi: 10.1148/radiol.2019191040. Epub 2019 Jun 11. No abstract available.

PMID:
31184982
4.

Utility and Outcomes of Imaging Evaluation for Palpable Lumps in the Postmastectomy Patient.

Dashevsky BZ, Hayward JH, Woodard GA, Joe BN, Lee AY.

AJR Am J Roentgenol. 2019 Aug;213(2):464-472. doi: 10.2214/AJR.18.20550. Epub 2019 Apr 30.

PMID:
31039027
5.

Initial experience of dedicated breast PET imaging of ER+ breast cancers using [F-18]fluoroestradiol.

Jones EF, Ray KM, Li W, Chien AJ, Mukhtar RA, Esserman LJ, Franc BL, Seo Y, Pampaloni MH, Joe BN, Hylton NM.

NPJ Breast Cancer. 2019 Apr 16;5:12. doi: 10.1038/s41523-019-0107-9. eCollection 2019.

6.

Utility of Diffusion-weighted Imaging to Decrease Unnecessary Biopsies Prompted by Breast MRI: A Trial of the ECOG-ACRIN Cancer Research Group (A6702).

Rahbar H, Zhang Z, Chenevert TL, Romanoff J, Kitsch AE, Hanna LG, Harvey SM, Moy L, DeMartini WB, Dogan B, Yang WT, Wang LC, Joe BN, Oh KY, Neal CH, McDonald ES, Schnall MD, Lehman CD, Comstock CE, Partridge SC.

Clin Cancer Res. 2019 Mar 15;25(6):1756-1765. doi: 10.1158/1078-0432.CCR-18-2967. Epub 2019 Jan 15.

7.

The Gambler's Fallacy in Screening Mammography.

Callen AL, Lobach I, Mesina O, Marcus S, Joe BN, Sickles EA, Greenwood HI.

J Am Coll Radiol. 2019 Jun;16(6):830-833. doi: 10.1016/j.jacr.2018.11.028. Epub 2019 Jan 2. No abstract available.

PMID:
30611683
8.

Characterization of Metastatic Sternal Lesions on Dynamic Contrast-Enhanced Breast MRI in Women with Invasive Breast Cancer.

Lee AY, Navarro R, Busby LP, Greenwood HI, Bucknor MD, Ray KM, Joe BN.

Acad Radiol. 2019 Oct;26(10):1358-1362. doi: 10.1016/j.acra.2018.11.011. Epub 2018 Dec 5.

PMID:
30527457
9.

Combined Benefit of Quantitative Three-Compartment Breast Image Analysis and Mammography Radiomics in the Classification of Breast Masses in a Clinical Data Set.

Drukker K, Giger ML, Joe BN, Kerlikowske K, Greenwood H, Drukteinis JS, Niell B, Fan B, Malkov S, Avila J, Kazemi L, Shepherd J.

Radiology. 2019 Mar;290(3):621-628. doi: 10.1148/radiol.2018180608. Epub 2018 Dec 11.

10.

Test-retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trial.

Newitt DC, Zhang Z, Gibbs JE, Partridge SC, Chenevert TL, Rosen MA, Bolan PJ, Marques HS, Aliu S, Li W, Cimino L, Joe BN, Umphrey H, Ojeda-Fournier H, Dogan B, Oh K, Abe H, Drukteinis J, Esserman LJ, Hylton NM; ACRIN Trial Team and I-SPY 2 TRIAL Investigators.

J Magn Reson Imaging. 2019 Jun;49(6):1617-1628. doi: 10.1002/jmri.26539. Epub 2018 Oct 22.

PMID:
30350329
11.

Microcalcifications Detected at Screening Mammography: Synthetic Mammography and Digital Breast Tomosynthesis versus Digital Mammography.

Lai YC, Ray KM, Lee AY, Hayward JH, Freimanis RI, Lobach IV, Joe BN.

Radiology. 2018 Dec;289(3):630-638. doi: 10.1148/radiol.2018181180. Epub 2018 Oct 2.

PMID:
30277445
12.

Paraneoplastic neurologic syndrome as a presentation of underlying breast malignancy.

Laguna B, Hayward JH, Lee AY, Joe BN, Ray KM.

Breast J. 2018 Nov;24(6):1038-1042. doi: 10.1111/tbj.13121. Epub 2018 Sep 21.

PMID:
30240068
13.

BI-RADS Category 5 Assessments at Diagnostic Breast Imaging:Outcomes Analysis Based on Lesion Descriptors.

Yao MM, Joe BN, Sickles EA, Lee CS.

Acad Radiol. 2019 Aug;26(8):1048-1052. doi: 10.1016/j.acra.2018.07.018. Epub 2018 Sep 5.

PMID:
30195413
14.

Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial.

Partridge SC, Zhang Z, Newitt DC, Gibbs JE, Chenevert TL, Rosen MA, Bolan PJ, Marques HS, Romanoff J, Cimino L, Joe BN, Umphrey HR, Ojeda-Fournier H, Dogan B, Oh K, Abe H, Drukteinis JS, Esserman LJ, Hylton NM; ACRIN 6698 Trial Team and I-SPY 2 Trial Investigators.

Radiology. 2018 Dec;289(3):618-627. doi: 10.1148/radiol.2018180273. Epub 2018 Sep 4.

15.

Overdiagnosis Should Not Be a Factor in Formulating Age-of-Onset and Screening-Interval Guidelines.

Joe BN.

AJR Am J Roentgenol. 2018 Jul;211(1):W79. doi: 10.2214/AJR.18.19632. No abstract available.

PMID:
29932768
16.

Role of MR Imaging for the Locoregional Staging of Breast Cancer.

Ray KM, Hayward JH, Joe BN.

Magn Reson Imaging Clin N Am. 2018 May;26(2):191-205. doi: 10.1016/j.mric.2017.12.008. Epub 2018 Feb 21. Review.

PMID:
29622125
17.

Tuberculosis mastitis presenting as bilateral breast masses.

Qiao Y, Hayward JH, Balassanian R, Ray KM, Joe BN, Lee AY.

Clin Imaging. 2018 Nov - Dec;52:28-31. doi: 10.1016/j.clinimag.2018.02.013. Epub 2018 Feb 23.

PMID:
29514120
18.

Sonographic-MRI Correlation After Percutaneous Sampling of Targeted Breast Ultrasound Lesions: Initial Experiences With Limited-Sequence Unenhanced MRI for Postprocedural Clip Localization.

Lee AY, Nguyen VT, Arasu VA, Greenwood HI, Ray KM, Joe BN, Price ER.

AJR Am J Roentgenol. 2018 Apr;210(4):927-934. doi: 10.2214/AJR.17.18489. Epub 2018 Feb 28.

PMID:
29489404
19.

Initial Clinical Experience With an Inducible Magnetic Seed System for Preoperative Breast Lesion Localization.

Price ER, Khoury AL, Esserman LJ, Joe BN, Alvarado MD.

AJR Am J Roentgenol. 2018 Apr;210(4):913-917. doi: 10.2214/AJR.17.18345. Epub 2018 Feb 15.

PMID:
29446680
20.

Clinical Breast Magnetic Resonance Imaging: Technique, Indications, and Future Applications.

Greenwood HI, Freimanis RI, Carpentier BM, Joe BN.

Semin Ultrasound CT MR. 2018 Feb;39(1):45-59. doi: 10.1053/j.sult.2017.07.002. Epub 2017 Jul 25. Review.

PMID:
29317039
21.

Screening for Breast Cancer in Women Age 75 Years and Older.

Lee CS, Moy L, Joe BN, Sickles EA, Niell BL.

AJR Am J Roentgenol. 2018 Feb;210(2):256-263. doi: 10.2214/AJR.17.18705. Epub 2017 Nov 7. Review.

PMID:
29112471
22.

Effect of Background Parenchymal Enhancement on Breast MR Imaging Interpretive Performance in Community-based Practices.

Ray KM, Kerlikowske K, Lobach IV, Hofmann MB, Greenwood HI, Arasu VA, Hylton NM, Joe BN.

Radiology. 2018 Mar;286(3):822-829. doi: 10.1148/radiol.2017170811. Epub 2017 Oct 25.

23.

Screening Mammography in Women 40-49 Years Old: Current Evidence.

Ray KM, Joe BN, Freimanis RI, Sickles EA, Hendrick RE.

AJR Am J Roentgenol. 2018 Feb;210(2):264-270. doi: 10.2214/AJR.17.18707. Epub 2017 Oct 24. Review.

PMID:
29064760
24.

Imaging Neoadjuvant Therapy Response in Breast Cancer.

Fowler AM, Mankoff DA, Joe BN.

Radiology. 2017 Nov;285(2):358-375. doi: 10.1148/radiol.2017170180. Review.

PMID:
29045232
25.

The Predicament of the Probably Benign Breast MRI: Should We Rely on Intuition?

Lee AY, Joe BN, Price ER.

Breast J. 2017 Sep;23(5):501-503. doi: 10.1111/tbj.12788. No abstract available.

PMID:
28914475
26.

Qualitative Radiogenomics: Association between Oncotype DX Test Recurrence Score and BI-RADS Mammographic and Breast MR Imaging Features.

Woodard GA, Ray KM, Joe BN, Price ER.

Radiology. 2018 Jan;286(1):60-70. doi: 10.1148/radiol.2017162333. Epub 2017 Sep 8.

PMID:
28885890
27.

Use of the probably benign (BI-RADS category 3) assessment for masses on breast MRI: Is it transferable to general clinical practice?

Price ER, Sickles EA, Yitta S, Brasic N, Yeh MJ, Allen IE, Joe BN.

Breast J. 2018 Mar;24(2):109-114. doi: 10.1111/tbj.12865. Epub 2017 Aug 27.

PMID:
28845605
28.

Value of diagnostic imaging for the symptomatic male breast: Can we avoid unnecessary biopsies?

Foo ET, Lee AY, Ray KM, Woodard GA, Freimanis RI, Joe BN.

Clin Imaging. 2017 Sep - Oct;45:86-91. doi: 10.1016/j.clinimag.2017.06.004. Epub 2017 Jun 9.

PMID:
28624748
29.

Radiologic-Pathologic Correlation for Benign Results After MRI-Guided Breast Biopsy.

Maglione KD, Lee AY, Ray KM, Joe BN, Balassanian R.

AJR Am J Roentgenol. 2017 Aug;209(2):442-453. doi: 10.2214/AJR.16.17048. Epub 2017 May 24. Review.

PMID:
28537753
30.

Evidence to Support Screening Women in Their 40s.

Ray KM, Price ER, Joe BN.

Radiol Clin North Am. 2017 May;55(3):429-439. doi: 10.1016/j.rcl.2016.12.002. Epub 2017 Jan 26. Review.

PMID:
28411671
31.

Can Radiologists Predict the Presence of Ductal Carcinoma In Situ and Invasive Breast Cancer?

Aminololama-Shakeri S, Flowers CI, McLaren CE, Wisner DJ, de Guzman J, Campbell JE, Bassett LW, Ojeda-Fournier H, Gerlach K, Hargreaves J, Elson SL, Retallack H, Joe BN, Feig SA, Wells CJ; ATHENA Breast Health Initiative.

AJR Am J Roentgenol. 2017 Apr;208(4):933-939. doi: 10.2214/AJR.16.16073. Epub 2017 Feb 15.

PMID:
28199152
32.

Dedicated Breast Positron Emission Tomography for the Evaluation of Early Response to Neoadjuvant Chemotherapy in Breast Cancer.

Jones EF, Ray KM, Li W, Seo Y, Franc BL, Chien AJ, Esserman LJ, Pampaloni MH, Joe BN, Hylton NM.

Clin Breast Cancer. 2017 Jun;17(3):e155-e159. doi: 10.1016/j.clbc.2016.12.008. Epub 2016 Dec 29. No abstract available.

PMID:
28110902
33.

Effect of MR Imaging Contrast Thresholds on Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes: A Subgroup Analysis of the ACRIN 6657/I-SPY 1 TRIAL.

Li W, Arasu V, Newitt DC, Jones EF, Wilmes L, Gibbs J, Kornak J, Joe BN, Esserman LJ, Hylton NM; ACRIN 6657 Trial Team and I-SPY Investigators Network.

Tomography. 2016 Dec;2(4):378-387. doi: 10.18383/j.tom.2016.00247.

34.

Inter-reader Variability in the Use of BI-RADS Descriptors for Suspicious Findings on Diagnostic Mammography: A Multi-institution Study of 10 Academic Radiologists.

Lee AY, Wisner DJ, Aminololama-Shakeri S, Arasu VA, Feig SA, Hargreaves J, Ojeda-Fournier H, Bassett LW, Wells CJ, De Guzman J, Flowers CI, Campbell JE, Elson SL, Retallack H, Joe BN.

Acad Radiol. 2017 Jan;24(1):60-66. doi: 10.1016/j.acra.2016.09.010. Epub 2016 Oct 25.

PMID:
27793579
35.

Improving Screening Mammography Outcomes Through Comparison With Multiple Prior Mammograms.

Hayward JH, Ray KM, Wisner DJ, Kornak J, Lin W, Joe BN, Sickles EA.

AJR Am J Roentgenol. 2016 Oct;207(4):918-924. Epub 2016 Jul 6.

36.

Follow-up outcomes after benign concordant MRI-guided breast biopsy.

Hayward JH, Ray KM, Wisner DJ, Joe BN.

Clin Imaging. 2016 Sep-Oct;40(5):1034-9. doi: 10.1016/j.clinimag.2016.06.005. Epub 2016 Jun 16.

PMID:
27348060
37.

Impact of Breast Density Legislation on Breast Cancer Risk Assessment and Supplemental Screening: A Survey of 110 Radiology Facilities.

Nayak L, Miyake KK, Leung JW, Price ER, Liu YI, Joe BN, Sickles EA, Thomas WR, Lipson JA, Daniel BL, Hargreaves J, Brenner RJ, Bassett LW, Ojeda-Fournier H, Lindfors KK, Feig SA, Ikeda DM.

Breast J. 2016 Sep;22(5):493-500. doi: 10.1111/tbj.12624. Epub 2016 Jun 14.

PMID:
27296462
38.

Concordance of BI-RADS Assessments and Management Recommendations for Breast MRI in Community Practice.

Lee AY, Ichikawa L, Lee JM, Lee CI, DeMartini WB, Joe BN, Wernli KJ, Sprague BL, Herschorn SD, Lehman CD.

AJR Am J Roentgenol. 2016 Jan;206(1):211-6. doi: 10.2214/AJR.15.14356.

39.

The Potential Impact of Risk-Based Screening Mammography in Women 40-49 Years Old.

Price ER, Keedy AW, Gidwaney R, Sickles EA, Joe BN.

AJR Am J Roentgenol. 2015 Dec;205(6):1360-4. doi: 10.2214/AJR.15.14668. Epub 2015 Jul 23.

PMID:
26204111
40.

Suspicious Findings at Digital Breast Tomosynthesis Occult to Conventional Digital Mammography: Imaging Features and Pathology Findings.

Ray KM, Turner E, Sickles EA, Joe BN.

Breast J. 2015 Sep-Oct;21(5):538-42. doi: 10.1111/tbj.12446. Epub 2015 Jul 6.

PMID:
26148173
41.

Internal mammary lymph nodes as incidental findings at screening breast MRI.

Ray KM, Munir R, Wisner DJ, Azziz A, Holland BC, Kornak J, Joe BN.

Clin Imaging. 2015 Sep-Oct;39(5):791-3. doi: 10.1016/j.clinimag.2015.05.011. Epub 2015 May 27.

PMID:
26072093
42.

Extra-mammary findings on breast MRI: a pictorial review.

Karp NL, Price ER, Wisner DJ, Chang CB, Hylton NM, Joe BN.

Clin Imaging. 2015 Jul-Aug;39(4):547-52. doi: 10.1016/j.clinimag.2015.01.019. Epub 2015 Feb 24. Review.

PMID:
25772531
43.

The developing asymmetry: revisiting a perceptual and diagnostic challenge.

Price ER, Joe BN, Sickles EA.

Radiology. 2015 Mar;274(3):642-51. doi: 10.1148/radiol.14132759. Review.

PMID:
25710339
44.

Breast density legislation: mandatory disclosure to patients, alternative screening, billing, reimbursement.

Ray KM, Price ER, Joe BN.

AJR Am J Roentgenol. 2015 Feb;204(2):257-60. doi: 10.2214/AJR.14.13558. Review.

PMID:
25615746
45.

Vaginal shape at resting pelvic MRI: predictor of pelvic floor weakness?

Tillack AA, Joe BN, Yeh BM, Jun SL, Kornak J, Zhao S, Deng D.

Clin Imaging. 2015 Mar-Apr;39(2):285-8. doi: 10.1016/j.clinimag.2014.10.007. Epub 2014 Oct 25.

PMID:
25457574
46.

The evolution of breast imaging: past to present.

Joe BN, Sickles EA.

Radiology. 2014 Nov;273(2 Suppl):S23-44. doi: 10.1148/radiol.14141233.

PMID:
25340437
47.

Breast MRI BI-RADS assessments and abnormal interpretation rates by clinical indication in US community practices.

Lee CI, Ichikawa L, Rochelle MC, Kerlikowske K, Miglioretti DL, Sprague BL, DeMartini WB, Wernli KJ, Joe BN, Yankaskas BC, Lehman CD.

Acad Radiol. 2014 Nov;21(11):1370-6. doi: 10.1016/j.acra.2014.06.003. Epub 2014 Aug 7.

48.

Response.

Price ER, Hargreaves J, Lipson JA, Sickles EA, Brenner RJ, Lindfors KK, Joe BN, Leung JW, Feig SA, Ojeda-Fournier H, Kurian AW, Love E, Ryan L, Ikeda DM.

Radiology. 2014 Jun;271(3):927-8. doi: 10.1148/radiol.14144013. No abstract available.

PMID:
24848959
49.

Repeatability of quantitative MRI measurements in normal breast tissue.

Aliu SO, Jones EF, Azziz A, Kornak J, Wilmes LJ, Newitt DC, Suzuki SA, Klifa C, Gibbs J, Proctor EC, Joe BN, Hylton NM.

Transl Oncol. 2014 Feb 1;7(1):130-7. eCollection 2014 Feb.

50.

High resolution in vivo characterization of apparent diffusion coefficient at the tumor-stromal boundary of breast carcinomas: a pilot study to assess treatment response using proximity-dependent diffusion-weighted imaging.

McLaughlin RL, Newitt DC, Wilmes LJ, Jones EF, Wisner DJ, Kornak J, Proctor E, Joe BN, Hylton NM.

J Magn Reson Imaging. 2014 May;39(5):1308-13. doi: 10.1002/jmri.24283. Epub 2013 Oct 8.

Supplemental Content

Support Center